Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,865 across all filing types
Latest filing 2018-09-24 Regulatory Filings
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos reports initiation of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in osteoarthritis patients
Regulatory Filings Classification · 95% confidence The document is a press release dated September 24, 2018, announcing the initiation of a Phase 2 clinical trial (ROCCELLA) for a drug candidate (GLPG1972/S201086) in osteoarthritis patients. It details the trial design, mechanism of action, previous trial results, collaboration terms, and includes standard forward-looking statements and contact information typical of corporate news releases. This content is not a formal regulatory filing like a 10-K, a comprehensive quarterly report (IR), or a specific shareholder document (DEF 14A, DVA). It is an announcement of operational and clinical progress, which most closely aligns with an Earnings Release (ER) if it were tied to a reporting period, or more generally, a Regulatory Filing (RNS) if it doesn't fit other specific categories. However, given the focus on clinical trial initiation and milestone payments, it functions as a significant operational update. Since it is not a formal financial report (like 10-K or IR) but a news announcement, and it doesn't fit the specific categories like M&A (TAR) or Capital Change (CAP), the most appropriate general category for a significant, non-financial-statement-focused operational update that is publicly released is often RNS (Regulatory Filings/General Announcement). If the company regularly issues these types of updates outside of formal earnings periods, RNS is the best fit among the provided options, as it is a general regulatory/corporate announcement.
2018-09-24 English
6-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, Galapagos NV. Form 6-K is used by foreign private issuers to furnish reports or documents required under the laws of their home country or exchange rules, often including press releases or other material information. The text explicitly states that the document includes a press release as Exhibit 99.1 and is incorporated by reference. The document length is only 2609 characters, which is quite short and consistent with a regulatory filing or announcement rather than a full report. There is no substantive financial data or detailed report content present. According to the rules, such a document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and includes Form 6-K filings that provide press releases or other information without full financial statements.
2018-09-24 English
Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million
Share Issue/Capital Change Classification · 99% confidence The document is a press release announcing the completion of a public offering of American Depositary Shares (ADSs), detailing the gross proceeds (€296.2 million), the price per ADS, and mentioning the involvement of underwriters (Morgan Stanley, Citigroup, etc.). It explicitly references filings made with the SEC, including a shelf registration statement and prospectus supplements. This activity—raising capital through the issuance of securities—directly corresponds to the definition of a Capital/Financing Update. The key phrases are: 'afkondigt afsluiting openbare aanbieding van American Depositary Shares' (announces closing of public offering of ADSs), 'bruto-opbrengst van €296,2 miljoen' (gross proceeds of €296.2 million), and references to SEC filings related to the offering. This strongly points to the 'Capital/Financing Update' category (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV).
2018-09-18 English
Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million
Share Issue/Capital Change Classification · 99% confidence The document is titled "Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million." It details the successful completion of an underwritten public offering of ADSs, including the price, gross proceeds, and the involvement of underwriters and book-running managers. This content directly relates to the company raising capital through the issuance of new securities (ADSs). This aligns perfectly with the definition of 'Capital/Financing Update' (CAP), which covers fundraising and capital structure changes. It is not an earnings release (ER), an annual report (10-K), or a general regulatory filing (RNS), as it describes a specific financing event.
2018-09-18 English
Galapagos issues new shares as result of public offering
Share Issue/Capital Change Classification · 99% confidence The document is titled "Galapagos geeft nieuwe aandelen als gevolg van openbare aanbieding" (Galapagos issues new shares as a result of a public offering) and explicitly announces a capital increase ('kapitaalverhoging') due to the public offering of American Depositary Shares. It details the resulting changes in share capital and the total number of voting rights. This content directly relates to fundraising, financing activities, and changes in capital structure. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (5327 chars) is substantial enough to be the primary announcement rather than just a brief RPA.
2018-09-18 English
Galapagos issues new shares as result of public offering
Share Issue/Capital Change Classification · 99% confidence The document explicitly states, "Galapagos issues new shares as result of public offering" and details the resulting change in total share capital and the number of voting rights. This directly relates to changes in the company's capital structure due to a financing activity (public offering of ADSs). This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it mentions share numbers, it is not a general share issue announcement (SHA) but a consequence of a specific financing event. It is not an earnings release, management discussion, or a formal regulatory filing like a 10-K or IR.
2018-09-18 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.